Global Investor Ideas - stock market news and investing podcasts for your next trading ideas
Global Investor Ideas - breaking stock market news and investing ideas
Featured Company:
Aethlon Medical, Inc. (NASDAQ: AEMD) is a medical therapeutic company focused on developing the Hemopurifier, a clinical stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. In human studies, the Hemopurifier has demonstrated the removal of life-threatening viruses and harmful exosomes from blood utilizing its proprietary lectin-based technology. This action has potential applications in cancer, where exosomes may promote immune suppression and metastasis, and in life-threatening infectious diseases. The Hemopurifier is a U.S. Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption (IDE) application related to the treatment of life-threatening viruses that are not addressed with approved therapies.
Get news alerts on this company!
August 19, 2024 (Globalinvestorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas, including biotech and pharma stocks reports on trading and news for Virax Biolabs Group Limited (NASDAQ: VRAX),…
August 12, 2024 (Globalinvestorideas.com Newswire) Globalinvestorideas.com, a go-to platform for big investing ideas, including biotech stocks reports on trading for Oragenics, Inc. (NYSE American: OGEN), a company focused on developing…
August 6, 2024 (Globalinvestorideas.com Newswire) Globalinvestorideas.com, a go-to platform for big investing ideas, including biotech stocks reports on trading for VBI Vaccines Inc. (Nasdaq: VBIV), a biopharmaceutical company driven by…
July 26, 2024 (Globalinvestorideas.com Newswire) Globalinvestorideas.com, a go-to platform for big investing ideas, including biotech stocks reports on trading for Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on…
June 26, 2024 (Globalinvestorideas.com Newswire) Globalinvestorideas.com, a go-to platform for big investing ideas, including biotech and pharma stocks reports on trading and news for ANEW MEDICAL, INC. (NASDAQ: WENA), a…
June 4, 2024 (Globalinvestorideas.com Newswire) Globalinvestorideas.com, a go-to platform for big investing ideas including biotech and medical tech stocks , reports on trading for SOBR Safe, Inc. (NASDAQ:SOBR), a provider…
May 28, 2024 (Globalinvestorideas.com Newswire) Globalinvestorideas.com, a go-to platform for big investing ideas, reports on trading for Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform…
April 11, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients…
April 10, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – Adial Pharmaceuticals, Inc. (NASDAQ: ADIL), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction…
April 8, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines is one of NASDAQ’s top gainers today and…
April 8, 2024 (Globalinvestorideas.com Newswire) Globalinvestorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch in the Biotech/Life Sciences sectors. The newest biotech companies…
April 5, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight…
Focus on Life Sciences; (Nasdaq:AUVI) (CSE:BETR) (OTC:FLHLF) (NASDAQ: OTRK) April 5, 2024 (Globalinvestorideas.com Newswire) Globalinvestorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch…
March 28, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – Avalo Therapeutics, Inc. (Nasdaq: AVTX) blew other stocks away making the NASDAQ top percentage gainer in today’s session, currently trading…
March 26, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein…
Life Sciences Stocks to Watch: (OTCPink:MRDH) (NASDAQ:PBM) (OTCQB:KRBP) (NASDAQ:OCEA) March 20, 2024 (Globalinvestorideas.com Newswire) Globalinvestorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch…
March 19, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – Enveric Biosciences (NASDAQ: ENVB), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of…
March 19, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com) Biotech Stock News Bites – Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates as precision medicines, saw…
March 18, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – Elicio Therapeutics, Inc. (Nasdaq: ELTX), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer,…
March 15, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies, has…